BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33474753)

  • 1. lncRNA FBXL19-AS1 is a diagnosis biomarker for paediatric patients with acute myeloid leukemia.
    Sheng H; Zhang J; Ma Y; Zhang Y; Dai Y; Jiang R
    J Gene Med; 2021 Mar; 23(3):e3317. PubMed ID: 33474753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA CD27-AS1 promotes acute myeloid leukemia progression through the miR-224-5p/PBX3 signaling circuit.
    Tao Y; Zhang J; Chen L; Liu X; Yao M; Zhang H
    Cell Death Dis; 2021 May; 12(6):510. PubMed ID: 34006845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A three‑lncRNA signature for prognosis prediction of acute myeloid leukemia in patients.
    Wang F; Tian X; Zhou J; Wang G; Yu W; Li Z; Fan Z; Zhang W; Liang A
    Mol Med Rep; 2018 Aug; 18(2):1473-1484. PubMed ID: 29901168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA FBXL19-AS1 induces tumor growth and metastasis by sponging miR-203a-3p in lung adenocarcinoma.
    Wang L; Zhang X; Liu Y; Xu S
    J Cell Physiol; 2020 Apr; 235(4):3612-3625. PubMed ID: 31566718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and Prognostic Potentials of Long Noncoding RNA ELF3-AS1 in Glioma Patients.
    Mei JC; Yan G; Mei SQ
    Dis Markers; 2020; 2020():8871746. PubMed ID: 33014189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of associations of FBXL19-AS1 with occurrence, development and prognosis of acute pancreatitis.
    Ma Q; Gan GF; Niu Y; Tong SJ
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12763-12769. PubMed ID: 33378025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum MicroRNA-370 as a potential diagnostic and prognostic biomarker for pediatric acute myeloid leukemia.
    Lin X; Wang Z; Wang Y; Feng W
    Int J Clin Exp Pathol; 2015; 8(11):14658-66. PubMed ID: 26823789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FBXL19-AS1 promotes cell proliferation and inhibits cell apoptosis via miR-876-5p/FOXM1 axis in breast cancer.
    Dong G; Pan T; Zhou D; Li C; Liu J; Zhang J
    Acta Biochim Biophys Sin (Shanghai); 2019 Nov; 51(11):1106-1113. PubMed ID: 31696201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA FBXL19-AS1 promotes proliferation and metastasis via regulating epithelial-mesenchymal transition in non-small cell lung cancer.
    Yu DJ; Li YH; Zhong M
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4800-4806. PubMed ID: 31210311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA LINC00899 as a novel serum biomarker for diagnosis and prognosis prediction of acute myeloid leukemia.
    Wang Y; Li Y; Song HQ; Sun GW
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7364-7370. PubMed ID: 30468482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of long non-coding RNA MBNL1-AS1 expression on prognosis of acute myeloid leukemia patients].
    Xie W; Qian TT; Pang Y; Ye X; Huang WH; Zhu P; Fu L
    Zhonghua Yi Xue Za Zhi; 2021 Apr; 101(13):934-938. PubMed ID: 33789374
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of seven novel ferroptosis-related long non-coding RNA signatures as a diagnostic biomarker for acute myeloid leukemia.
    Zheng Z; Wu W; Lin Z; Liu S; Chen Q; Jiang X; Xue Y; Lin D
    BMC Med Genomics; 2021 Sep; 14(1):236. PubMed ID: 34579730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of lncRNA FGD5-AS1 correlates with poor prognosis in melanoma patients.
    Gao Y; Zhu H; Mao Q
    J Gene Med; 2020 Dec; 22(12):e3278. PubMed ID: 32997827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF2BP2 stabilized FBXL19-AS1 regulates the blood-tumour barrier permeability by negatively regulating ZNF765 by STAU1-mediated mRNA decay.
    Liu X; Wu P; Su R; Xue Y; Yang C; Wang D; Ruan X; Zheng J; Yang Y; Li Z; Liu Y
    RNA Biol; 2020 Dec; 17(12):1777-1788. PubMed ID: 32713259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum level of lncRNA-HIF1A-AS1 as a novel diagnostic predictor for worse prognosis in colorectal carcinoma.
    Gong W; Tian M; Qiu H; Yang Z
    Cancer Biomark; 2017 Dec; 20(4):417-424. PubMed ID: 28946548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non‑coding RNA LINC00460 serves as a potential biomarker and oncogene via regulation of the miR‑320b/PBX3 axis in acute myeloid leukemia.
    Zhuang Q; Jin Z; Zheng X; Jin T; Xiang L
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33846790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long Noncoding RNA FBXL19-AS1-Mediated Ulcerative Colitis-Associated Intestinal Epithelial Barrier Defect.
    Zhao X; Cui DJ; Yang LC; Yuan WQ; Yan F
    Tissue Eng Regen Med; 2022 Oct; 19(5):1077-1088. PubMed ID: 36048401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA GAS6 antisense RNA1 silencing attenuates the tumorigenesis of acute myeloid leukemia cells through targeting microRNA-370-3p/Tetraspanin3 axis.
    Lei W; Lin J; Liu F; Chen N
    Clin Hemorheol Microcirc; 2021; 78(1):69-81. PubMed ID: 33523043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum LncRNA-ATB and FAM83H-AS1 as diagnostic/prognostic non-invasive biomarkers for breast cancer.
    El-Ashmawy NE; Hussien FZ; El-Feky OA; Hamouda SM; Al-Ashmawy GM
    Life Sci; 2020 Oct; 259():118193. PubMed ID: 32763293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Long Noncoding RNA ZNF667-AS1 as a Potential Biomarker for Diagnosis and Prognosis of Glioma Patients.
    Yuan Q; Gao C; Lai XD; Chen LY; Lai TB
    Dis Markers; 2020; 2020():8895968. PubMed ID: 33282010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.